2311 - 2320 of 9156 Results
Title
Year
- Hybrid deep brain stimulation system to manage stimulation-induced side effects in essential tremor patients2018RESTRICTEDTitle: Hybrid deep brain stimulation system to manage stimulation-induced side effects in essential tremor patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 58Issue #:Start Page: 85End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.07.013Citation Count: 16
-
OPENTitle: Effects of parkinsonism on health status in welding exposed workersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 672End Page: 676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3200492Citation Count: 22
- TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects2018OPENTitle: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite EffectsJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 64Issue #: 3Start Page: 341End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4Best OA location URL: https://zenodo.org/record/3911331Citation Count: 17
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2016RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 64
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 29
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 85
- Parallel development of Parkinson's-specific competencies for exercise professionals and criteria for exercise education programs2023RESTRICTEDTitle: Parallel development of Parkinson's-specific competencies for exercise professionals and criteria for exercise education programsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 112Issue #:Start Page: 105407End Page: 105407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105407Citation Count: 4
-
OPENTitle: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 CasesJournal Name: Sleep DisordersPublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2011/468952Best OA location URL: https://downloads.hindawi.com/journals/sd/2011/468952.pdfCitation Count: 10
-
OPENTitle: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 2Start Page: 106End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51482Citation Count: 44
-
OPENTitle: The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced DyskinesiaJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22010020Best OA location URL: https://www.mdpi.com/1422-0067/22/1/20/pdf?version=1608635348Citation Count: 11